Tag: Cancer immunotherapy

Ciltacabtagene Autoleucel CAR T Therapy for High-Risk Smoldering Multiple Myeloma

April 21, 2026

Ciltacabtagene Autoleucel CAR T Therapy for High-Risk Smoldering Multiple Myeloma

Synthetic Super-Enhancers Enable Precision Viral Immunotherapy

April 9, 2026

Synthetic Super-Enhancers Enable Precision Viral Immunotherapy

Neoadjuvant Ipilimumab Nivolumab Melanoma Survival Biomarkers

January 28, 2026

Neoadjuvant Ipilimumab Nivolumab Melanoma Survival Biomarkers

Neoantigen Vaccine for Lynch Syndrome Cancer Prevention: Phase 1b/2 Trial Results

January 16, 2026

Neoantigen Vaccine for Lynch Syndrome Cancer Prevention: Phase 1b/2 Trial Results

Web Analytics